Association between interleukin-36γ and tumor progression in non-small cell lung cancer

Immunotherapy is effective in improving the survival and prognosis of patients with non-small cell lung cancer (NSCLC), and identifying effective immunomarkers is important for immunotherapy. Interleukin (IL)-36γ is a novel immunomarker that has an important function in the antitumor immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lin, He, Honghong, Xu, Dan, Feng, Yuehua, Zhou, Huijun, Shi, Liyan, Gu, Yanzheng, Wang, Jian, Zhu, Yibei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039103/
https://www.ncbi.nlm.nih.gov/pubmed/32194745
http://dx.doi.org/10.3892/ol.2020.11319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039103/
https://www.ncbi.nlm.nih.gov/pubmed/32194745
http://dx.doi.org/10.3892/ol.2020.11319

Ejemplares similares